期刊论文详细信息
Current oncology
Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer— a patient survey
D. Fergusson1  J. Hilton2  S. Gertler3  A. Robinson4  M. Ibrahim5  C. Stober6  N. LeVasseur7  S. McDiarmid8 
[1] Cross Cancer Institute;The Ottawa Hospital Research Institute;University of Ottawa;Cancer Centre of Southeastern Ontario;The Ottawa Hospital;The Ottawa Hospital Research Institute;The Ottawa Hospital and University of Ottawa;University of Alberta
关键词: Early-stage breast cancer;    patient surveys;    vascular access;   
DOI  :  10.3747/co.25.3911
学科分类:肿瘤学
来源: Multimed, Inc.
PDF
【 摘 要 】

BackgroundThe choice of vascular access for systemic therapy administration in breast cancer remains an area of clinical equipoise, and patient preference is not consistently acknowledged. Using a patient survey, we evaluated the patient experience with vascular access during treatment for early-stage breast cancer and explored perceived risk factors for lymphedema. MethodsPatients who had received systemic therapy for early-stage breast cancer were surveyed at 2 Canadian cancer centres. ResultsResponses were received from 187 patients (94%). The route of vascular access was peripheral intravenous line (IV) in 24%, a peripherally inserted central catheter (picc) in 42%, and a surgically inserted central catheter (port) in 34%. Anthracycline-based regimens were associated with a greater use of central vascular access devices (cvads— that is, a picc or port; 86/97, 89%). Trastuzumab use was associated with greater use of ports (49/64, 77%). Although few patients (7%) reported being involved in the decisions about vascular access, most were satisfied or very satisfied (88%) with their access type. Patient preference centred mainly on avoiding delays in the initiation of chemotherapy. Self-reported rates of complications (183 evaluable responses) were infiltration with peripheral IVs (9/44, 20%), local skin infections with piccs (7/77, 9%), and thrombosis with ports (4/62, 6%). Perceived risk factors for lymphedema included use of the surgical arm for blood draws (117/156, 75%) and blood pressure measurement (115/156, 74%). ConclusionsMost patients reported being satisfied with the vascular access used for their treatment. Improved education and understanding about the evidence-based requirements for vascular access are needed. Perceived risk factors for lymphedema remain variable and are not evidence-based.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201910250816651ZK.pdf 268KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:17次